Medication Administration Records for NDIS Providers — What the MAR Must Capture

Why Medication Documentation Is Critical for NDIS Providers

For NDIS participants, medications are often central to managing complex health conditions. Errors in medication administration — wrong dose, wrong time, missed dose, wrong person — can have serious health consequences. The MAR is your organisation's record that medications were managed correctly.

The NDIS Quality and Safeguards Commission can request medication records during audits. Gaps in the MAR — missing entries, unsigned administrations, no record of refusals — are non-conformances against the NDIS Practice Standards.

What Every MAR Entry Must Include

For each medication administration event, the record must capture:

• Participant name — unique identifier to prevent wrong-person errors
• Medication name — exact name as prescribed, not abbreviations
• Dose — amount administered
• Route — oral, topical, inhaled, etc.
• Scheduled time — the intended administration time
• Actual time administered — timestamped record of when it was actually given
• Name of the staff member who administered it
• Outcome — taken, refused, or unable to administer with reason

Any variation from the prescribed schedule must be documented with a reason.

Recording Refusals — the Most Overlooked Step

A participant has the right to refuse medication. This is a rights-based provision of the NDIS. But a refusal must be documented — not just left blank on the MAR.

When a participant refuses a medication, the MAR entry should record:

• That the medication was offered and refused
• The time of the refusal
• Any reason given by the participant (if known)
• What the worker did next — notified manager? Left medication for later? Documented for the clinical record?

A pattern of refusals for a specific medication should be escalated to a prescriber or the clinical team. The MAR is the only place this pattern becomes visible.

High-Risk Medications — Additional Requirements

Certain medications carry higher risk due to their narrow therapeutic window or potential for serious adverse effects. These typically include medications for epilepsy, mental health conditions, blood thinners, and strong pain medications.

For high-risk medications, many providers require:

• A double-check before administration — a second staff member witnesses the dose and co-signs the MAR
• Additional monitoring after administration — vital signs check, observation period
• Specific documentation of the participant's response

Your medication management policy should define which medications in your participants' medication lists are classified as high-risk and what additional steps apply to each.

PRN Medications — Every Use Must Be Documented

PRN medications — given as needed rather than on a fixed schedule — require particularly careful documentation because each administration is a separate clinical decision. The MAR entry for a PRN medication must also record:

• The indication — what symptom or condition prompted the administration
• The effect — what change, if any, was observed after administration
• Whether medical advice was sought if the PRN was needed more frequently than expected

Under the NDIS, PRN medications used for behaviour management are classified as restrictive practices and require additional documentation and reporting.

Why Paper MARs Create Risk

Paper MARs have significant failure modes:

• Entries completed hours after the event — memory errors, guessing at times
• Illegible handwriting creating ambiguity about what was given
• Lost or damaged forms — especially in community settings where workers carry forms on shifts
• No alert when a scheduled medication is missed — paper forms are passive
• No automatic escalation when a pattern of refusals emerges

A digital MAR addresses every one of these failure modes: timestamped entries at the point of care, typed entries, cloud storage, alerts for missed medications, and automatic pattern visibility.